AzTrials
AzTrials

StrokePhase 1NCT02892097

Transcranial Direct Current Stimulation (tDCS) and Task-Specific Practice for Post-stroke Neglect

A Phase 1 study testing tDCS and Repetitive task-specific practice (RTP) in people with Stroke and Hemispatial Neglect, run by Medical University of South Carolina at 1 site in United States.

Terminated

Stopped early. The study ended before it was planned to and will not resume.

Official record
Search all trials

Trial summary

The purpose of this study is to test the effects of three different rehabilitation training sessions that combine non-invasive brain stimulation (transcranial direct current stimulation, tDCS) with arm rehabilitation training (repetitive task-specific practice, RTP) for individuals with unilateral spatial neglect… Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Stroke, Hemispatial Neglect
What is being tested?
tDCS and Repetitive task-specific practice (RTP)
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
1 participants
Where
1 siteUnited States
Study dates
Jul 2016to 7 Nov 2017
Phase
Phase 1
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Unilateral hemispheric ischemic stroke or hemorrhagic subcortical stroke ≥3 months post stroke (lesion type and location to be confirmed with MRI)
  • Neglect (Virtual Reality Lateralized Attention Test score <18)
  • Upper extremity Fugl-Meyer score between 20-56/60
  • Inducible motor evoked potential (MEP) of the abductor pollicis brevis (APB) on the affected side using transcranial magnetic stimulation (TMS)
  • ≥18 years old

Who cannot join

  • History of cortical hemorrhagic stroke
  • Severe spasticity (Modified Ashworth Scale score ≥3) in paretic upper extremity
  • Severe aphasia limiting participant's ability to follow 2 step directions
  • History of seizures
  • History of brain tumor
  • History of skull defect
Show all 12Show fewer
  • Hardware in skull or spine (e.g. coils, clips)
  • Implantable medical device (e.g. pacemaker)
  • Metal in body that is not compatible with MRI
  • Pregnant (women of child bearing age will be asked if they are pregnant or could possibly be pregnant)
  • Unable to travel to Upper Extremity Motor Function Laboratory at the Center for Rehabilitation Research in Neurological Conditions
  • Currently enrolled in another study using transcranial direct current stimulation (tDCS) or transcranial magnetic stimulation (TMS)

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Medical University of South Carolina

    Charleston, South Carolina, 29425

Other trials in United States

About this study

Official title: Examining the Effects of Transcranial Direct Current Stimulation and Task-specific Practice on Cortical Modulation Among Individuals With Unilateral Spatial Neglect Post Stroke

The purpose of this study is to test the effects of three different rehabilitation training sessions that combine non-invasive brain stimulation (transcranial direct current stimulation, tDCS) with arm rehabilitation training (repetitive task-specific practice, RTP) for individuals with unilateral spatial neglect following stroke. This study is designed to determine the effects of tDCS + RTP on the excitability in the brain, attention to the affected side, and arm movement ability.

Read the detailed description

Unilateral neglect (neglect) is common after stroke and is characterized by an inattention to one side of the body or environment. There is growing evidence that disconnections to fronto-parietal neural networks in the lesioned hemisphere not only cause neglect, but also cause these same networks to be hyperexcited in the non-lesioned hemisphere. Individuals with neglect typically experience motor impairments also since the regions of the brain that control attention also control movement.

Transcranial direct current stimulation (tDCS) when paired with repetitive task-specific practice (RTP) has the potential to modulate cortical activity (fronto-parietal networks) and facilitate motor and attentional recovery for individuals with neglect since tDCS can modulate the excitability of targeted cortical regions. tDCS is a form on non-invasive brain stimulation and RTP is the gold standard post-stroke motor recovery intervention.

It is particularly important investigators examine the effect of RTP + tDCS on cortical modulation in order to understand the underlying mechanism of the intervention and determine whether RTP+ tDCS (parietal or primary motor cortex [M1]) promotes greater neural modulation than RTP alone. Traditionally, electrodes are placed on M1 to facilitate motor recovery and on the parietal lobe to facilitate attentional recovery, however this intervention is designed to target each of these impairments (motor, attention) and enhance cortical modulation of fronto-parietal networks. Therefore, investigators must also determine the optimal electrode montage and placement for pairing tDCS with RTP for individuals with neglect.

The purpose of the proposed pilot project is to examine the effects of transcranial direct current stimulation (tDCS) paired with repetitive task-specific practice (RTP) on modulation of fronto-parietal network connectivity (measured by transcranial magnetic stimulation [TMS]), motor impairment (measured with kinematic assessment), and attentional impairment (measured with Behavioral Inattention Test) among individuals with unilateral neglect and hemiparesis post stroke. This three day cross-over design study will examine the optimal electrode placement and montage using 3 conditions: (1) tDCS to parietal lobe + RTP (2) tDCS to primary motor cortex + RTP (3) sham tDCS + RTP.

Being tested
tDCS, sham tDCS, Repetitive task-specific practice (RTP)
Keywords
tDCS, neglect, paresis, transcranial direct current stimulation, rehabilitation
Medical subject headings
Stroke, Perceptual Disorders, Paresis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • tDCSDevice

    Also called noninvasive brain stimulation, transcranial direct current stimulation

    tDCS is a form of noninvasive brain stimulation. Electrodes are placed on the scalp (parietal or primary motor cortex) and deliver a low level of direct current (2mA). tDCS will be delivered for 30 minutes in conjunction with repetitive task-specific practice for the arm/hand.

  • sham tDCSDevice

    Sham tDCS will be delivered for 30 minutes in conjunction with repetitive task-specific practice for the arm/hand.

  • Repetitive task-specific practice (RTP)Behavioural

    Also called task practice

    Participants will practice using their paretic arm/hand to complete functional movements during each (3) 30 minute training session.

Study groups in NCT02892097
Study groupRoleWhat they receive
Parietal tDCS plus RTPActive comparatorSingle session of bilateral parietal tDCS (2.0 mA for 30 minutes) paired with repetitive task-specific practice (RTP).
Receives: Device: tDCS; Behavioral: Repetitive task-specific practice (RTP)
Primary motor cortex tDCS plus RTPActive comparatorSingle session of bilateral primary motor cortex tDCS (2.0 mA for 30 minutes) paired with repetitive task-specific practice (RTP)
Receives: Device: tDCS; Behavioral: Repetitive task-specific practice (RTP)
Sham tDCS plus RTPSham comparatorSingle session of sham tDCS (for 30 minutes) paired with repetitive task-specific practice (RTP)
Receives: Device: sham tDCS; Behavioral: Repetitive task-specific practice (RTP)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in excitability of fronto-parietal connectivity

    Excitability of fronto-parietal connectivity measured by paired pulse twin coil transcranial magnetic stimulation (TMS) test. In each session, the difference in excitability of fronto-parietal connectivity between pre and post stimulation will be measured.

    Measured: Participants will be assessed at baseline and 30 minutes later (immediately following intervention session).

Secondary outcomes (2)
  1. Change in kinematics

    A kinematic assessment will be conducted to assess changes in motor impairment.

    Measured: Participants will be assessed at baseline and 1 hour later (immediately following intervention session).

  2. Change on Behavioral Inattention Test

    A neglect assessment will be conducted to assess changes in attentional impairment.

    Measured: Participants will be assessed at baseline and 1.5 hours later (immediately following intervention session).

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Sep 2016 (estimated)
  2. Study startJul 2016
  3. Primary completion7 Nov 2017
  4. Study completion7 Nov 2017

Why it stopped: Enrolled 1 participant, PI left the institution.

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 1
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Crossover
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
1 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02892097
Sponsor's protocol ID
PRO00056688
Other IDs
P2CHD086844
Status last verified
Sep 2021
First submitted
10 Aug 2016
Last updated
13 Sep 2021
Results posted
No
Data monitoring committee
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A Phase 1 study testing tDCS and Repetitive task-specific practice (RTP) in people with Stroke and Hemispatial Neglect, run by Medical University of South Carolina at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 12 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: stopped early, as of the sponsor's last update on 13 Sep 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 1 studies test a treatment in a small group of people for the first time or in a new way, mainly to check safety and find the right dose.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study was stopped early (reason given: Enrolled 1 participant, PI left the institution.). Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in excitability of fronto-parietal connectivity (time frame: Participants will be assessed at baseline and 30 minutes later (immediately following intervention session).). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Sep 2021.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in
Clinical Trial NCT02892097 | AzTrials